Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -3.39%13B | -9.56%3.23B | -0.39%3.03B | 0.27%3.71B | -3.59%3.04B | 5.65%13.46B | 2.82%3.57B | 6.75%3.04B | 4.08%3.7B | 9.95%3.15B |
Cost of revenue | -2.70%8.55B | -9.87%2.09B | -1.11%1.96B | 2.97%2.5B | -2.81%2.01B | 12.83%8.79B | 3.94%2.32B | 12.88%1.98B | 12.17%2.42B | 25.72%2.06B |
Gross profit | -4.69%4.45B | -8.91%1.14B | 0.85%1.07B | -4.85%1.22B | -5.06%1.03B | -5.66%4.67B | 0.73%1.25B | -3.20%1.06B | -8.32%1.28B | -11.27%1.09B |
Operating expense | 1.41%3.89B | -1.40%915M | 2.63%977M | 1.09%1.02B | 3.26%981M | -7.11%3.84B | -7.75%928M | -5.56%952M | -8.93%1.01B | -6.03%950M |
Staff costs | -1.50%918M | ---- | ---- | ---- | ---- | 0.11%932M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 1.46%1.74B | ---- | ---- | ---- | ---- | -15.41%1.72B | ---- | ---- | ---- | ---- |
-Selling and marketing expense | -0.61%1.29B | ---- | ---- | ---- | ---- | -10.70%1.3B | ---- | ---- | ---- | ---- |
-General and administrative expense | 7.93%449M | ---- | ---- | ---- | ---- | -27.40%416M | ---- | ---- | ---- | ---- |
Other operating expenses | 3.61%1.23B | ---- | ---- | ---- | ---- | 1.54%1.19B | ---- | ---- | ---- | ---- |
Operating profit | -32.97%555M | -30.82%220M | -15.09%90M | -27.24%195M | -63.24%50M | 1.72%828M | 37.66%318M | 24.71%106M | -5.96%268M | -36.15%136M |
Net non-operating interest income (expenses) | 0 | -1M | 0 | 0 | 1M | 0 | 0 | 0 | 0 | 0 |
Non-operating interest income | 0.00%2M | --0 | --1M | --0 | --1M | 0.00%2M | 0.00%1M | --0 | 0.00%1M | --0 |
Non-operating interest expense | 0.00%2M | 0.00%1M | --1M | --0 | --0 | 100.00%2M | --1M | --0 | --1M | --0 |
Net investment income | -33.33%10M | -20.00%8M | 1M | 50.00%15M | 400.00%10M | 150.00%5M | ||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 3M | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -97.98%2M | -101.25%-1M | 3M | 0 | 0 | 482.35%99M | 80M | 0 | 19M | 0 |
Less:Other special charges | 96.97%-3M | --0 | ---- | ---- | ---- | -482.35%-99M | ---80M | --0 | ---- | ---- |
Less:Write off | --1M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -50.00%3M | -150.00%-1M | 100.00%2M | 0.00%1M | -50.00%1M | 133.33%6M | 110.00%2M | 1M | 1M | 2M |
Income before tax | -40.23%566M | -46.21%220M | -12.28%100M | -30.36%195M | -64.58%51M | 15.91%947M | 97.58%409M | 28.09%114M | -8.20%280M | -33.33%144M |
Income tax | -28.82%247M | -35.85%102M | -2.50%39M | -23.00%77M | -39.58%29M | 38.80%347M | 133.82%159M | 110.53%40M | 12.36%100M | -35.14%48M |
Net income | -46.74%319M | -52.40%119M | -18.92%60M | -33.52%119M | -78.13%21M | 5.83%599M | 79.86%250M | 5.71%74M | -16.74%179M | -32.39%96M |
Net income continuous operations | -46.83%319M | -52.80%118M | -17.57%61M | -34.44%118M | -77.08%22M | 5.82%600M | 79.86%250M | 5.71%74M | -16.67%180M | -32.39%96M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -46.74%319M | -52.40%119M | -18.92%60M | -33.52%119M | -78.13%21M | 5.83%599M | 79.86%250M | 5.71%74M | -16.74%179M | -32.39%96M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -46.74%319M | -52.40%119M | -18.92%60M | -33.52%119M | -78.13%21M | 5.83%599M | 79.86%250M | 5.71%74M | -16.74%179M | -32.39%96M |
Gross dividend payment | ||||||||||
Basic earnings per share | -46.71%75.08 | -52.43%27.92 | -18.10%14.21 | -34.06%27.8 | -77.30%5.15 | 5.61%140.89 | 78.77%58.69 | 5.54%17.35 | -16.75%42.16 | -32.25%22.69 |
Diluted earnings per share | -46.71%75.08 | -52.43%27.92 | -18.86%14.0775 | -33.89%27.8 | -77.30%5.15 | 5.61%140.89 | 79.44%58.69 | 5.54%17.35 | -16.88%42.048 | -32.25%22.69 |
Dividend per share | -11.54%46 | -23.08%20 | 0 | 0.00%26 | 0 | 0.00%52 | 0.00%26 | 0 | 0.00%26 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |